4.5 Review

Combined modality management of advanced cervical cancer including novel sensitizers

Journal

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Volume 32, Issue 3, Pages 246-259

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/ijgc-2021-003137

Keywords

cervical cancer; surgery; radiotherapy

Funding

  1. National Medical Research Council, Singapore [MOH--FLWSHP19may--0006]

Ask authors/readers for more resources

The management of advanced cervical cancer has evolved over time, with combined modality treatment involving surgery, radiotherapy, and systemic therapy showing improved outcomes. This article reviews recent advances and international guidelines in the management of cervical cancer.
The management of advanced cervical cancer has evolved with time. Combined modality treatments for cervical cancer have been shown to improve clinical outcomes for these patients. The role of surgery is reviewed in this article for specific situations such as the treatment of bulky lymph nodes and even in the metastatic setting. External beam radiotherapy and brachytherapy techniques have improved which has decreased patient toxicity. Systemic therapy such as chemotherapy, immunotherapy, and novel sensitizing agents have been extensively studied and have shown promising results. The combination of these three different modalities of treatment can be tailored to each specific patient to achieve the best outcomes. We review the recent advances and various international guidelines for the management of cervical cancer in this article.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available